ITGB1 and glioblastoma: Previous study has indicated that ITGB1 immunostaining was heterogeneous in both intensity and frequency, and its distribution was patchy throughout the glioblastoma tumor sample with strongly positive immunostaining signal often close to the necrotic regions [32].